APSR2026-31

Yes
Late-Breaking
Submitted
Poster Presentation
 
AP11-001
P43
 
Format: PPTX Only
https://storage.unitedwebnetwork.com/files/1285/1198254-46904-Poster_APSR 2026_Xiao-Yue (vertical)_439141.pdf
Format: PDF Only
09. Asthma
6

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Kun-Ta Lee - Taipei Medical University-Shuang Ho Hospital Respiratory Therapy, Division of Pulmonary Medicine,Department of Internal Medicine New Taipei City Taiwan
Mei-Chun Chen - Taipei Medical University-Shuang Ho Hospital Division of Pulmonary Medicine, Department ofInternal Medicine New Taipei City Taiwan
Po-Hao Feng - Taipei Medical University-Shuang Ho Hospital Division of Pulmonary Medicine, Department ofInternal Medicine New Taipei City Taiwan
Kuan-Yuan Chen - Taipei Medical University-Shuang Ho Hospital Division of Pulmonary Medicine, Department ofInternal Medicine New Taipei City Taiwan
Tzu-Tao Chen - Taipei Medical University-Shuang Ho Hospital Division of Pulmonary Medicine, Department ofInternal Medicine New Taipei City Taiwan
Xiao-Yue Chen * Taipei Medical University School of Respiratory Therapy, College of Medicine Taipei Taiwan
 
 
 
 
 
 
 
 
 
Presenting Author Details
Xiao-Yue
Chen
xychen@tmu.edu.tw
+886988949113
Under 30
Taiwan
Original Research
Longitudinal association between fractional exhaled nitric oxide (FeNO) and small airway dysfunction: a path toward personalized asthma control
Maximum 25 words
Abstract Content
Asthma remains a major public health issue, and achieving optimal control remains a global challenge. While fractional exhaled nitric oxide (FeNO) is a recognized biomarker for type 2 airway inflammation, its ability to reflect small airway injury remains unclear. This study aimed to evaluate the longitudinal associations between FeNO and parameters of both PFT and IOS to determine the utility of FeNO as a predictor of small airway impairment in precision asthma monitoring.
In this prospective longitudinal study, 36 asthma patients underwent serial assessments of FeNO, PFT, and IOS at 2 to 3-month intervals during three consecutive visits. Intrasubject associations were evaluated using repeated-measures Pearson correlation. A generalized estimating equation (GEE) was employed to assess the longitudinal predictive value of FeNO on pulmonary function, adjusting for clinical covariates including disease severity, age, body mass index (BMI), and the use of biologics or corticosteroids. Ethics approval was obtained.
We observed that FeNO levels exhibited significant negative correlations with mean forced expiratory flow at 25–75% (MFEF25-75) and forced expiratory flow at 25% (FEF25) (p < 0.05). Conversely, IOS-derived parameters of small airway resistance (R5–R20) and resonance frequency (Fres) showed significant positive correlations with FeNO (p < 0.05). Multi-variable GEE analysis further confirmed that FeNO was an independent longitudinal predictor of forced expiratory volume in 1 second (FEV1, %) and FEF25 (p < 0.05). Notably, increased baseline FeNO levels significantly predisposed patients to subsequent MFEF25-75 < 70% and R5–R20 > 0.07 kPa/(L/s) (p < 0.05).
Our findings suggest that FeNO may be a sensitive indicator of small airway dysfunction, supporting its role as a surrogate of distal airway injury. We propose a novel role for FeNO monitoring in future precision management of asthma.
 
 
 
 
 
No
No
 
JPG or JPEG or PNG format ONLY
pulmonary function, small airway, type 2 inflammation
maximum 3 keywords and no abbreviations, separated by commas
The authors declare that they have no conflicts of interest. The authors thank Shih-Heng Lin for technical support.
283